Search company, investor...

Predict your next investment

Inflect Health company logo
Venture Capital
inflecthealth.com

Investments

20

Portfolio Exits

3

Partners & Customers

3

About Inflect Health

Inflect Health invests in the healthcare sector.

Headquarters Location

Emeryville, California, 94608,

United States

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Inflect Health News

David Maman and Divya Chander to Keynote CharmHealth Third Annual Innovation Challenge & Showcase

Aug 11, 2023

Final Call for Proposals to be Considered for Funding, Mentorship and Partnership Opportunities PLEASANTON, Calif.–(BUSINESS WIRE)– #AI — CharmHealth , a leading provider of healthcare technology solutions, today announced that Binah.ai CEO and Founder David Maman and Divya Chander , chair of neuroscience, faculty in medicine at Singularity University, will be the keynote speakers for the 2023 Innovation Challenge . Maman and Chander will address key challenges facing the healthcare industry while providing advice to startups, entrepreneurs, students and nonprofits on how they can effectively create and deploy solutions. Talks will be delivered at CharmHealth’s signature event being held Sept. 2-3 at Asilomar Conference Center in Monterey, California. “We are delighted to welcome David and Divya as keynote speakers at this year’s Innovation Challenge,” said Pramila Srinivasan , Ph.D., CEO of CharmHealth. “I am certain that all Challenge participants will learn a great deal from their experiences, knowledge and passion for creating a healthier world. David and Divya will set the perfect tone for this incredible event.” Maman’s Binah.ai is a leader in health and wellness check software which makes health data more accessible for better care at lower costs. Under his leadership, Binah.ai has been recognized as a top startup, winning several awards, including the health and wellness innovation award at CES. As a serial entrepreneur and startup mentor, he has guided numerous companies from inception to execution to acquisition. Maman’s management style and startup acumen led him to be named one of the “Top 40 Israeli Internet Startup Professionals” by The Marker Magazine and one of the “Top 40 under 40 – Most Promising Israeli Business Professionals” by Globes Magazine. Dr. Divya Chander is a physician, neuroscientist and futurist who trained at Harvard, UCSF, UCSD and the Salk Institute. She is currently the chair of neuroscience and faculty in medicine at Singularity University . She is also a visiting scholar in the Stanford Department of Medicine, Biomedical Informatics, and was a member of the Stanford Anesthesiology Faculty for eight years. Dr. Chander has a precision medicine initiative focused on understanding genetic variability in responses to anesthetic drugs and brain oscillations. One of the goals across her work is to understand neural mechanisms of consciousness as well as the evolution of human consciousness secondary to human augmentation. Additional speakers include David Fajgenbaum , M.D., MBA, MSc, physician-scientist at the University of Pennsylvania and co-founder of Every Cure ; Joshua Tamayo-Sarver , M.D., Ph.D., FACEP, FAMIA, vice president of innovation at Vituity and Inflect Health ; Aman Rajpal , M.D., chief of endocrinology at Alameda Health System; Uli Chettipally , M.D., MPH, founder and president of InnovatorMD ; and Ramesh Dontha , founder and CEO of The AI Entrepreneurs . Last Call for Proposals The 2023 Innovation Challenge is a unique event that provides a platform for digital health thought leaders to share groundbreaking ideas with investors, incubators and partners who can bring them to market and effectively advance care. Representatives from Inflect Health and Bioverge will be on hand throughout the Innovation Challenge to connect with participants. These firms have strong track records of investing in exceptional organizations. Inflect Health’s recent investments include Biocogniv and Decoded Health , while Bioverge recently invested in My Diabetes Tutor and GigaMune. To participate in the Innovation Challenge, organizations and entrepreneurs are invited to submit proposals until Aug.15, 2023, to be considered for Pitch Day. The 15 selected finalists will then present their solutions to an innovation panel for the chance to win cash prizes as well as the opportunity to secure funding, partnerships and mentorship. Submissions will be considered across six focus areas, broadly defined to encourage a range of disruptive ideas and solutions. Focus areas for proposals include: Telehealth and Telemedicine, Tech-led Innovations, Digital Therapeutics, Drug Discovery, mHEALTH and Disease Management. Innovators can submit in one of four categories: Startup Entrepreneurs, Developers, Students or Nonprofits and Research Groups. In addition to access to capital, partners and mentors — as well as participating in fruitful knowledge exchange and collaboration — finalists also have the opportunity to integrate their products or solutions with CharmHealth’s existing platform. This integration can offer significant market access, distribution channels and exposure to a wide customer base, accelerating the growth and adoption of the winning startups. CharmHealth has received numerous honest reviews of its products including accolades from our users on the Software Advice platform, recently acquired by Gartner. In fact, CharmEHR was rated as the best overall pick and best value for money among urgent care EMR peers while the CharmHealth Patient Engagement Portal was rated as the best overall pick and best value for money among family practice EMR peers. Additionally, CharmTelehealth secured best overall pick and best value for money and CharmBillerPro led the way among medical billing products peers. CharmHealth was also recently named the Best E-Prescribing Software for Small to Midsized Practices by Forbes. To participate in the CharmHealth Innovation Challenge, interested individuals, startups and organizations can submit their proposals through the official challenge website at https://charmhealthchallenge.com/ . The submission period closes on Aug. 15, 2023. All submissions will be carefully evaluated by a panel of esteemed judges with expertise in healthcare technology and innovation. For more information about the CharmHealth Innovation Challenge, including guidelines, eligibility criteria, and important dates, please visit the challenge website or contact [email protected] . About CharmHealth CharmHealth is a leading provider of innovative healthcare technology solutions that empower healthcare organizations to deliver efficient, high-quality care. With a focus on interoperability, patient engagement, and streamlined workflows, CharmHealth offers a comprehensive suite of solutions designed to meet the evolving needs of modern healthcare. For more information on CharmHealth, visit www.charmhealth.com . To get breaking news, follow the company @charmhealth and on Facebook at www.facebook.com/charmhealth . The Software Advice logo is a service mark of Gartner, Inc. and/or its affiliates and is used herein with permission. All rights reserved. Gartner Digital Markets reviews are shared across its different brands sites and constitute the subjective opinions of individual end users based on their own experiences and do not represent the views of Gartner or its affiliates. All brand names and solution names are trademarks or registered trademarks of their respective companies. Tags: CharmHealth, Innovation Challenge, Pramila Srinivasan, AI, artificial intelligence, generative AI, digital health, healthcare, health care, healthcare innovation, venture capital, healthcare investment, telehealth, telemedicine, disease management, mHealth, insurtech Contacts TECHMarket Communications

Nov 11, 2022
Fathom Health

Inflect Health Investments

20 Investments

Inflect Health has made 20 investments. Their latest investment was in MACRO Trials as part of their Seed VC on June 6, 2023.

CBI Logo

Inflect Health Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/21/2023

Seed VC

MACRO Trials

$6M

Yes

1

6/7/2023

Seed VC - II

Karoo Health

$3.4M

Yes

6

2/7/2023

Seed VC

Joystik

$0.2M

Yes

1

12/21/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

11/16/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/21/2023

6/7/2023

2/7/2023

12/21/2022

11/16/2022

Round

Seed VC

Seed VC - II

Seed VC

Series A

Seed VC

Company

MACRO Trials

Karoo Health

Joystik

Subscribe to see more

Subscribe to see more

Amount

$6M

$3.4M

$0.2M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

6

1

10

10

Inflect Health Portfolio Exits

3 Portfolio Exits

Inflect Health has 3 portfolio exits. Their latest portfolio exit was Healthful on February 28, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/28/2023

Merger

Healthful

$99M

1

11/30/2021

Spinoff / Spinout

Subscribe to see more

$99M

Subscribe to see more

10

10/5/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/28/2023

11/30/2021

10/5/2021

Exit

Merger

Spinoff / Spinout

Acquired

Companies

Healthful

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Inflect Health Partners & Customers

3 Partners and customers

Inflect Health has 3 strategic partners and customers. Inflect Health recently partnered with Gen1E Lifesciences on May 5, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

5/12/2022

Partner

United States

Inflect Health Expands its Strategic Partnership with GEn1E Lifesciences to Combat Rare & Inflammatory Diseases

EMERYVILLE , Calif. and PALO ALTO , Calif. , May 12 , 2022 / PRNewswire / -- Inflect Health , the innovation hub of Vituity , a physician-owned and operated partnership with 3500 + physicians across 350 + hospitals and 8M patients in the United States , announces the expansion of its strategic partnership with GEn1E Lifesciences , a next-generation biotech company developing novel and targeted immunomodulators for rare and inflammatory diseases , to further accelerate the development of GEn1E 's powerful machine learning platform .

1

3/22/2022

Vendor

United States

Subscribe to see more

Subscribe to see more

10

5/10/2021

Client

United States

Subscribe to see more

Subscribe to see more

10

Date

5/12/2022

3/22/2022

5/10/2021

Type

Partner

Vendor

Client

Business Partner

Country

United States

United States

United States

News Snippet

Inflect Health Expands its Strategic Partnership with GEn1E Lifesciences to Combat Rare & Inflammatory Diseases

EMERYVILLE , Calif. and PALO ALTO , Calif. , May 12 , 2022 / PRNewswire / -- Inflect Health , the innovation hub of Vituity , a physician-owned and operated partnership with 3500 + physicians across 350 + hospitals and 8M patients in the United States , announces the expansion of its strategic partnership with GEn1E Lifesciences , a next-generation biotech company developing novel and targeted immunomodulators for rare and inflammatory diseases , to further accelerate the development of GEn1E 's powerful machine learning platform .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Inflect Health Team

2 Team Members

Inflect Health has 2 team members, including current Chief Executive Officer, Rick Newell.

Name

Work History

Title

Status

Rick Newell

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Rick Newell

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Status

Current

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.